Live Breaking News & Updates on Spiral Therapeutics Inc

Stay updated with breaking news from Spiral therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Spiral Therapeutics Announces Collaboration with the Vestibular Disorders Association (VeDA), Advancing Patient-Centric Care in Neurotology

/PRNewswire/ Spiral Therapeutics, Inc. ("Spiral"), a clinical-stage pharmaceutical company leading the way in therapies for inner ear disorders, today. ....

United States , Cynthia Ryan , Vestibular Disorders Association Ve , Vestibular Disorders Association , Spiral Therapeutics Inc , Spiral Therapeutics , Hugo Peris , Executive Director , Investigational New Drug ,

Spiral Therapeutics Welcomes New Investment, Cementing Its Leadership in Neurotology

/PRNewswire/ Spiral Therapeutics, Inc. ("Spiral"), a clinical-stage company focused on delivering therapies for inner ear disorders, today announced a new. ....

Prnewswire Spiral Therapeutics Inc , Spiral Therapeutics Inc , Esperante Ventures , Ferring Ventures , Dean Slagel , Managing Director , Investigational New Drug , Spiral Therapeutics , Health Care Amp Hospitals , Medical Pharmaceuticals , Small Business Services , Venture Capital , Clinical Trials Amp Medical Discoveries ,

Spiral Therapeutics Acquires Otonomy Assets to Boost Inner Ear Disorders Pipeline and Appoints Industry Leaders to Board

/PRNewswire/ Spiral Therapeutics, Inc. ("Spiral"), a clinical-stage company focused on delivering therapies for inner ear disorders, announced today the. ....

Anthony Adamis , Fred Guerard , Anthony Tony Adamis , Otonomy Inc , Development Innovation At Genentech , Roche Group , Prnewswire Spiral Therapeutics Inc , Drug Administration , Spiral Therapeutics Inc , Product Development , Spiral Therapeutics , Brain Derived Neurotrophic Factor , Development Innovation , Graybug Vision , Hugo Peris , Chief Executive Officer , Eugene De Juan , Executive Chairman ,

Spiral Therapeutics Completes $8.25M Financing and Initiates Phase 2 Trial in Ménière's Disease

/PRNewswire/ Spiral Therapeutics, Inc. ("Spiral"), a clinical-stage company focused on delivering therapies for inner ear disorders, today announced that. ....

United States , Jafri Kuthubutheen , Division Of Surgery , Prnewswire Spiral Therapeutics Inc , Humboldt Fund , National Institute Of Deafness , Spiral Therapeutics Inc , University Of Western Australia , Savoir Capital , Catalio Capital Management , National Institute , Clinical Associate Professor , Medical School , Western Australia , Principal Investigator , Charles Limb , Chief Medical Officer , Hugo Peris , Chief Executive Officer , Spiral Therapeutics ,